Evidence map›Paper›PMID 31517704›Full record

ArticleCognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology2019

Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis.

Jessica F Baird, Katie L J Cederberg, E Morghen Sikes, Brenda Jeng, Jeffer E Sasaki, Brian M Sandroff, Robert W Motl

Abstract read
In one paragraph

Article in Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Clinical and functional profile of very old people with multiple sclerosis: a cross-sectional study in the genoa area.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Symptom clusters and quality of life in persons with multiple sclerosis across the lifespan.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica F BairdDepartment of Physical Therapy.
Katie L J CederbergDepartment of Physical Therapy.
E Morghen SikesDepartment of Physical Therapy.
Brenda JengDepartment of Physical Therapy.
Jeffer E SasakiGraduate Program in Physical Education, Federal University of Triangulo Mineiro, Uberaba, Minas Gerais, Brazil.
Brian M SandroffDepartment of Physical Therapy.
Robert W MotlDepartment of Physical Therapy.

Funding

Rehabilitation Research Resource to Enhance Clinical Trials (ReACT)P2CHD086851 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2015 to 2019
$7.1M
UAB Pre-Doctoral Training Program in Obesity-Related ResearchT32HL105349 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2010 to 2026
$5.7M
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.T32HD071866 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAMES RIMMER, Anna E. Thalacker-Mercer · 2012 to 2026
$4.8M
The essentiality of serine and glycine for skeletal muscle regeneration in agingR01AG075059 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI THALACKER-MERCER, ANNA E. · 2022 to 2025
$1.5M
NHLBI NIH HHS T32 HL105349NIA NIH HHS R01 AG075059NICHD NIH HHS P2C HD086851NICHD NIH HHS T32 HD071866
6 · The paper itself

Abstract

backgroundCognitive impairment is one of the most common consequences of multiple sclerosis (MS), yet there is a shortage of data regarding how cognition changes during the life span of individuals with MS. This information is of increasing importance given the growing proportion of older adults with MS.

objectiveTo study possible changes in cognitive function in correlation with increasing age in individuals with MS.

methodsParticipants (N=129) were recruited and a priori allocated into one of three age groups (young, middle-aged, and older). All participants completed the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) during a single laboratory testing session. The BICAMS measures cognitive processing speed as well as verbal and visuospatial learning and memory.

resultsA multivariate analysis of variance indicated that cognitive function significantly differed by age group, and these differences were not explained by amount of physical activity, years of education, years since diagnosis, or race. Older adults displayed significantly worse cognitive processing speed than young and middle-aged adults. The older and middle-aged adults also demonstrated significantly worse visuospatial learning and memory than the younger adults. Effect sizes indicated that cognitive processing speed and verbal learning and memory were more affected in late adulthood than early adulthood, whereas visuospatial learning and memory was affected similarly in early and late adulthood.

conclusionsOlder adults with MS demonstrated significant impairments in cognitive function compared to young and middle-aged adults with MS. Future studies should determine the predictors of cognitive decline in this age cohort.

Indexed as

AdultAgedAge FactorsCognition DisordersCross-Sectional StudiesFemaleHumansMaleMiddle AgedMultiple SclerosisYoung Adult

Identifiers

PMID31517704
PMCPMC6750025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.